期刊文献+

乙型肝炎病毒多表位治疗性抗原基因的合成、表达及抗原性研究 被引量:7

Synthesis,cloning,expression and antigenicity of the therapeutic multi-epitope gene of hepatitis B virus and of its products
暂未订购
导出
摘要 目的研究乙型肝炎病毒多表位治疗性疫苗基因的合成、表达及其产物的抗原性。方法设计、并合成乙型肝炎病毒多表位抗原基因BPT,克隆入融合表达载体pWR450-1,构建重组质粒PWR/BPT。在大肠杆菌中表达乙型肝炎多表位抗原蛋白并纯化该蛋白,并用Western-blotting方法初步检测该抗原蛋白的抗原性。结果成功构建了融合表达载体PWR/BPT,在大肠杆菌中表达出乙型肝炎多表位抗原蛋白,Western-blotting 检测显示该蛋白具有良好抗原性。结论HBV多表位治疗性抗原基因的设计是成功的,其在大肠杆菌中表达的重组融合蛋白具有良好的抗原性,可能是较理想的HBV治疗性疫苗候选物。 Objective To study the synthesis, cloning, expression and antigenicity of therapeutic multi-epitope gene of hepatitis B virus. Methods The therapeutic multi-epitope gene of hepatitis B virus was synthesized and cloned into the vector pWR450-1, then was expressed in E.coli and the products were purified. The immunogenicity of the expressed protein was analyzed by Western-blotting. Results Recombinant plasmid PWR/BPT was constructed successfully and the protein of multiepitope gene of hepatitis B virus was expressed in E.coli, which showed ideal antigenicity by Western-blotting. Conclusions The designed multi-epitope therapeutic gene of hepatitis B virus was proved to be correct and the expressed protein may be a good therapeu- tic vaccine.
出处 《第一军医大学学报》 CSCD 北大核心 2003年第8期802-805,共4页 Journal of First Military Medical University
基金 国家自然科学基金(30170532) 广东省自然科学基金(990375) 广州市重点攻关课题(2001-2-035-01)~~
关键词 乙型肝炎 多表位 治疗性疫苗 hepatitis B virus, multi-epitope, therapeutic vaccine
  • 相关文献

参考文献8

  • 1Vitiello A, Ishioka G, Howard M, et al. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection [J]. J Clin Invest, 1995, 95(1): 341-9.
  • 2Jon C. Vaccine get a new twist [J]. Science, 1994, 264: 503-5.
  • 3Cho SP, Lee B , Min MK, et al. Recombinant polioviruses expressing hepatitis B virus-specific eytotoxic T-lymphocyte epitopes [J].Vaccine, 2000, 118(25): 2878-85.
  • 4Davis HL, Weeratna R, Waldschmidt TT, et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen[J]. J Immunol, 1998, 160: 870-6.
  • 5Isaka M, Yasuda Y, Mizokami M, et al. Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as on adjuvant[J]. Vaccine, 2001, 19(11-12): 1460-6.
  • 6Davis HL, Suparto II, Weeraatna RR, et al. CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans [J ]. Vaccine,2000, 18: 1920-4.
  • 7Chisari FV, Rous W, Award Lecture. Viruses, immunity, and cancer:lessons from hepatitis B[J]. Am J Pathol, 2000, 156(2): 1117-32.
  • 8Livingston BD, Crimi C, Grey H, et al. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection[J]. J Immunol,1997, 159(3): 1383-92.

同被引文献113

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部